1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Community Health Systems completed the sale of four Arkansas hospitals and associated outpatient centers to Freeman Health System on June 1, 2026, for $110 million in cash before certain transaction expenses, subject to a post-closing working capital adjustment. The unaudited pro forma figures show an estimated pre-tax loss on the sale of $55 million and lower 2025 results without these facilities, including diluted EPS of $3.50 versus $3.77 as reported.
Closed June 1, 2026; the purchase agreement was signed March 5, 2026, with Freeman Health System as purchaser
Facilities sold: Northwest Medical Center in Bentonville (128 beds), Springdale (222 beds), Willow Creek Women's Hospital in Johnson (64 beds), and Siloam Springs Regional Hospital (73 beds)
Pro forma estimated pre-tax loss on sale of $55 million ($48 million after tax)
Pro forma 2025 net operating revenues of $12,070 million versus $12,485 million as reported
Penguin Solutions said Chief Financial Officer Nate Olmstead will resign effective July 8, 2026, to pursue an opportunity in a different industry, and that the departure is not related to any disagreement with the company. Vice President of Finance and Accounting Aaron Johnson will serve as interim CFO from July 9, 2026, while the company searches for a permanent CFO. The company also reaffirmed its fiscal 2026 outlook and expects net sales and diluted EPS at the high end of its outlook ranges, which matters to shareholders because it signals the company still expects strong results despite the finance leadership change.
Nate Olmstead resigns as Senior Vice President and CFO effective July 8, 2026, and will receive no severance benefits
Aaron Johnson, 47, named interim CFO and principal financial and accounting officer effective July 9, 2026
Company reaffirmed fiscal 2026 outlook and expects net sales and diluted EPS at the high end of outlook ranges
Company will report third-quarter fiscal 2026 results on July 7, 2026, and has begun a search for a permanent CFO
CPS Technologies Corp. sold 1,200,000 shares of common stock at $8.00 per share in a registered direct offering, with the closing on May 29, 2026. The company expects about $9.0 million in net proceeds, which it plans to use for general corporate purposes, and it raised its authorized common shares from 20,000,000 to 25,000,000. The sale adds cash but also increases the number of shares outstanding, which dilutes existing shareholders.
Sold 1,200,000 shares at $8.00 per share; gross proceeds of about $9.6 million, priced at-the-market under Nasdaq rules
Net proceeds of about $9.0 million after placement agent fees and offering expenses; Roth Capital Partners received a 5.5% cash fee
Company agreed not to issue more shares or convertible securities for 45 days after the May 29, 2026 closing, and not to enter certain variable rate transactions for 180 days
Certificate of Amendment increasing authorized common stock from 20,000,000 to 25,000,000 was filed May 27, 2026
IFF agreed on May 28, 2026 to sell its Food Ingredients business to affiliates of CVC Capital Partners at a valuation of about $4.3 billion, with expected net cash proceeds of about $3.8 billion plus a minority stake worth about $200 million. IFF says it plans to use the proceeds mainly to reduce debt and buy back shares, but expects the deal to be dilutive to adjusted EPS in the first 12 months after closing.
Buyer is Foxtrot US Bidco, Inc., an affiliate of CVC Capital Partners; deal values the business at about $4.3 billion, or about 10x enterprise value to EBITDA per the press release
IFF expects net cash proceeds of about $3.8 billion at closing and a minority stake of about 9.9%, valued at about $200 million
The business generated nearly $3.1 billion in 2025 sales and about $430 million of EBITDA; IFF expects the deal to be dilutive to adjusted EPS in the first 12 months after closing
Closing is expected by the end of the second quarter of 2027; either party may terminate if not consummated by May 28, 2027; IFF reiterated its full-year 2026 guidance
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.